v3.26.1
Note 8 - Noncontrolling Interest - Clyra Medical (Tables)
6 Months Ended
Jun. 30, 2026
Notes Tables  
Schedule of Other Ownership Interests [Table Text Block]
  

Clyra Options Outstanding

  Weighted average price per share  

Weighted average remaining life

 

Balance, December 31, 2024

  1,976,863  $1.00     

Granted

  50,664  $4.50     

Balance, June 30, 2025

  2,027,527  $1.09     

Unvested

  (200,000) $0.01     

Vested Balance, June 30, 2025

  1,827,527  $1.21     
             

Balance, December 31, 2025

  3,013,692  $2.01     

Granted

  232,143  $4.46     

Exercised

  (500,000) $0.01     

Balance, June 30, 2026

  2,745,835  $2.58   7.6 

Unvested

  (719,791) $4.19     

Vested Balance, June 30, 2026

  2,026,044  $2.01   7.0 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  

2026

  

2025

 
  

Non Plan

  

2024 Plan

  

Non Plan

  

2024 Plan

 

Risk free interest rate

     4.30 - 4.47%  4.23%  4.23 - 4.58%

Expected volatility

     84%  91%  90 - 91%

Expected dividend yield

            

Forfeiture rate

            

Life in years

     10   10   10 
Warrants Outstanding for Noncontrolling Interest [Table Text Block]
  

Clyra Warrants Outstanding

  

Weighted average price per share

  

Weighted average remaining life

 

Balance, December 31, 2024

  1,183,182  $4.84     

Granted

  470,002  $6.94     

Expired

  (224,944) $7.24     

Vested Balance, June 30, 2025

  1,428,240  $4.87     
             

Balance, December 31, 2025

  1,702,496  $5.39     

Granted

  226,344  $7.50     

Expired

  (358,810) $3.72     

Vested Balance, June 30, 2026

  1,570,030  $6.13   1.8 
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]

Category

 

BioLargo

  

ONM

  

BLEST

  

BioLargo Canada

  

BETI

  

BEST

  

Intercompany amounts

  

Totals

 

Accounts payable

 $468  $270  $5  $134  $  $  $(3) $874 

Accrued payroll

  50   73   250   -      -      373 

Total

                             $1,247 

Category

 

BioLargo

  

ONM

  

BLEST

  

BioLargo Canada

  

BETI

  

BEST

  

Intercompany amounts

  

Totals

 

Accounts payable

 $588  $305  $  $100   43  $  $(24) $1,012 

Accrued payroll

  10   85   73   22      9      199 

Total

                             $1,211 
Clyra Medical [Member]  
Notes Tables  
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]

Category

 

2026

  

2025

 

Accounts payable

 $489  $634 

Accrued dividend

  1,109   937 

Accrued payroll

  31   21 

Total

 $1,629  $1,592 
Finance Lease, Liability, to be Paid, Maturity [Table Text Block]

Year ending

    

December 31, 2026

 $75 

December 31, 2027

  150 

December 31, 2028

  150 

Total minimum lease payments

 $375 

Less imputed interest

  (64)

Total finance lease liabilities

 $311 
Clyra Medical Technologies [Member]  
Notes Tables  
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  

June 30, 2026

  

June 30, 2025

 

Risk free interest rate

  4.20 - 4.36%  4.36 - 4.45%

Expected volatility

  35 - 39%  35 - 43%

Expected dividend yield

      

Forfeiture rate

      

Expected life in years

  10   10